These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2129251)

  • 1. [Advances in fibrinolysis mediated by vascular endothelial cells].
    Zhou QS
    Sheng Li Ke Xue Jin Zhan; 1990 Oct; 21(4):318-22. PubMed ID: 2129251
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of vascular endothelial cells in the regulation of fibrinolysis.
    Grulich-Henn J; Müller-Berghaus G
    Z Kardiol; 1989; 78 Suppl 6():25-9. PubMed ID: 2694664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-urokinase: physiochemical properties and promotion of its fibrinolytic activity by urokinase and by tissue plasminogen activator with which it has a complementary mechanism of action.
    Gurewich V
    Semin Thromb Hemost; 1988 Jan; 14(1):110-5. PubMed ID: 3127884
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
    Félez J; Rueda F
    Sangre (Barc); 1985; 30(4-C):779-86. PubMed ID: 3937250
    [No Abstract]   [Full Text] [Related]  

  • 5. [Plasminogen activators in tumor tissue].
    Tomasiuk R; Mirowski M; Wierzbicki R
    Pol Arch Med Wewn; 1989 Jun; 81(6):355-63. PubMed ID: 2517455
    [No Abstract]   [Full Text] [Related]  

  • 6. Physiological consequences of loss of plasminogen activator gene function in mice.
    Carmeliet P; Schoonjans L; Kieckens L; Ream B; Degen J; Bronson R; De Vos R; van den Oord JJ; Collen D; Mulligan RC
    Nature; 1994 Mar; 368(6470):419-24. PubMed ID: 8133887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activators and inhibitor type-1 in alveolar osteitis.
    Serratì S; Margheri F; Bruschi S; D'Alessio S; Pucci M; Fibbi G; Tonelli P; Del Rosso M
    Eur J Oral Sci; 2006 Dec; 114(6):500-3. PubMed ID: 17184232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the pericellular fibrinolytic system in angiogenesis.
    Fukao H; Ueshima S; Okada K; Matsuo O
    Jpn J Physiol; 1997 Apr; 47(2):161-71. PubMed ID: 9201545
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.
    Sabovic M; Lijnen HR; Keber D; Collen D
    Thromb Haemost; 1989 Dec; 62(4):1083-7. PubMed ID: 2515603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of plasminogen activators.
    Robbins KC; Barlow GH; Nguyen G; Samama MM
    Semin Thromb Hemost; 1987 Apr; 13(2):131-8. PubMed ID: 3114881
    [No Abstract]   [Full Text] [Related]  

  • 11. Endothelium in hemostasis and thrombosis.
    Lijnen HR; Collen D
    Prog Cardiovasc Dis; 1997; 39(4):343-50. PubMed ID: 9050819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.
    Louise CB; Obrig TG
    Microvasc Res; 1994 May; 47(3):377-87. PubMed ID: 8084301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the fibrinolytic system in corneal angiogenesis.
    Vogten JM; Reijerkerk A; Meijers JC; Voest EE; Borel Rinkes IH; Gebbink MF
    Angiogenesis; 2003; 6(4):311-6. PubMed ID: 15166500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human plasminogen activators. Genes and proteins structure.
    Blasi F; Riccio A; Sebastio G
    Horiz Biochem Biophys; 1986; 8():377-414. PubMed ID: 3093360
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of fibrin and plasminogen activators in repair-associated angiogenesis: in vitro studies with human endothelial cells.
    van Hinsbergh VW; Koolwijk P; Hanemaaijer R
    EXS; 1997; 79():391-411. PubMed ID: 9002228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Position and developmental trends in fibrinolytic therapy].
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):6-17. PubMed ID: 2427416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. At the interface of fibrinolysis and inflammation: the role of urokinase-type plasminogen activator in the leukocyte extravasation cascade.
    Reichel CA; Kanse SM; Krombach F
    Trends Cardiovasc Med; 2012 Oct; 22(7):192-6. PubMed ID: 23062972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.
    Orbe J; Chordá C; Montes R; Páramo JA
    Haematologica; 1999 Apr; 84(4):306-11. PubMed ID: 10190943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue type plasminogen activator facilitates NMDA-receptor-mediated retinal apoptosis through an independent fibrinolytic cascade.
    Kumada M; Niwa M; Hara A; Matsuno H; Mori H; Ueshima S; Matsuo O; Yamamoto T; Kozawa O
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1504-7. PubMed ID: 15790922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the synthesis and secretion of plasminogen activators by endothelial cells.
    van Hinsbergh VW
    Haemostasis; 1988; 18(4-6):307-27. PubMed ID: 3148525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.